Afghanistan Technical Report: Interim Findings and Conclusions of Drug Financing


During the course of its work in Afghanistan, the SPS program has identified multiple challenges confronting the pharmaceutical system in Afghanistan that combine to limit the access to quality pharmaceuticals by the Afghan population. These challenges include weak enforcement of pharmaceutical policy and regulations and increased availability of pharmaceutical products of low and/or questionable quality from neighboring countries. In order to examine this issue further, SPS sought and was granted approval from USAID to conduct further investigations into the financing of essential medicines in Afghanistan.